COVID-19 outbreak: An experience to reappraise the role of hospital at home in the anti-cancer drug injection

Autor: Laurence Nivet, Laurent Havard, Benedicte Mittaine-Marzac, Jean‐Christophe Crusson, Valerie Cheneau, Taina Louissaint, Matthieu De Stampa, Elisabeth Balladur, Fatma Amrani, Marie‐Claire Pinel, Marie‐Laure Brandely‐Piat, Philippe Aegerter, Arsene Zogo, Joël Ankri
Přispěvatelé: Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, AP-HP - Hôpital Cochin Broca Hôtel Dieu [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
Rok vydání: 2020
Předmět:
0301 basic medicine
Male
Cancer Research
[SDV]Life Sciences [q-bio]
Home Care Services
Hospital-Based

Medical Oncology
home-based hospital
Disease Outbreaks
0302 clinical medicine
Neoplasms
Health care
Pandemic
Child
Original Research
education.field_of_study
Middle Aged
lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
3. Good health
Oncology
030220 oncology & carcinogenesis
Child
Preschool

Female
France
Public Health
COVID‐19‐Organisation
medicine.medical_specialty
Coronavirus disease 2019 (COVID-19)
Population
Antineoplastic Agents
lcsh:RC254-282
COVID-19-Organisation
03 medical and health sciences
Breast cancer
medicine
Humans
cancer
Radiology
Nuclear Medicine and imaging

education
Pandemics
Aged
home‐based hospital
business.industry
SARS-CoV-2
pandemic
Outbreak
Cancer
COVID-19
Clinical Cancer Research
medicine.disease
030104 developmental biology
Concomitant
Emergency medicine
business
Zdroj: Cancer Medicine
Cancer Medicine, Vol 10, Iss 7, Pp 2242-2249 (2021)
Cancer Medicine, Wiley, 2021, 10 (7), pp.2242-2249. ⟨10.1002/cam4.3682⟩
ISSN: 2045-7634
Popis: Background The COVID‐19 outbreak has posed considerable challenges to the health care system worldwide, especially for cancer treatment. We described the activity and the care organisation of the Hospitalisation At Home (HAH) structure during the pandemic for treating patients with anti‐cancer injections. Methods We report the established organisation, the eligibility criteria, the patient characteristics, the treatment schemes and the stakeholders’ role during two 5‐week periods in 2020, before and during the French population's lockdown. Results The increase of activity during the lockdown (+32% of treated patients, +156% of new patients and +28% of delivered preparations) concerned solid tumour, mainly breast cancer, even if haematological malignancies remained the most frequent. Thirty different drugs were delivered, including three new drugs administered in HAH versus 19 during the routine period (p
HAH could be used to decrease unnecessary travel to hospital and allow further anti‐cancer treatments and follow‐up from home particularly during the pandemic period. HAH should be included in guidelines for cancer administration and not restricted to follow‐up or oral treatment. It is necessary to rethink the classical cancer management scheme and develop alternative models of health service delivery such as home programs to manage this public health issue in both the short‐ and also long‐term.
Databáze: OpenAIRE